nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

01.02.2016 | Retinal Disorders

The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy

verfasst von: Hsi-Kung Kuo, Yi-Hao Chen, Faye Huang, Yi-Chan Wu, Jentaie Shiea, Pei-Chang Wu

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Proteins in the vitreous play an important role on the induction of proliferative vitreoretinopathy (PVR) after retinal detachment. The aim of this study was to investigate the variation of protein patterns in the vitreous of PVR eyes and examine whether differentially expressed protein levels were expressed in experimental PVR retina.

Methods

Vitreous samples from PVR and macular hole patients were selected for proteomic analysis. The vitreous protein samples were separated by two-dimensional electrophoresis (2-DE). The differentially expressed protein spots in the two groups were excised and subjected to in-gel digestion and identification by electrospray ionization mass spectrometry (ESI-MS) analysis. Two differentially expressed proteins, zinc finger protein 670 (ZFP 670) and prostaglandin D2 synthase (PGD2S), were further validated by immunohistochemical staining and western blotting analysis in the retina of the experimental rabbit PVR model.

Results

In proteome analysis of human vitreous samples, five proteins had increased expression in PVR, including zinc finger protein 670 (ZFP 670), prostaglandin D2 synthase (PGD2S), IgG (Immunoglobulin G) light chain, transthyretin precursor, and haptoglobin precursor. ZFP 670 and PGD2S levels were expressed significantly higher in the experimental PVR retinas than in the control group.

Conclusions

Levels of ZFP 670 and PGD2S were elevated in the vitreous fluid of patients with PVR. In addition, there were higher expressions of ZFP 670 and PGD2S in the experimental PVR retina. This result will expand our knowledge of pathophysiologic characteristics of PVR, and might be helpful for further developing possible treatment on this disorder.

Chignell AH, Fison LG, Davies EW, Hartley RE, Gundry MF (1973) Failure in retinal detachment surgery. Br J Ophthalmol 57:525–530PubMedPubMedCentralCrossRef

Heimann H, Bartz-Schmidt KU, Bornfeld N, Weiss C, Hilgers RD, Foerster MH (2007) Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study. Ophthalmology 114:2142–2154PubMedCrossRef

Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746PubMedCrossRef

Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG (2005) Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 46:329–342PubMedCrossRef

Vinores SA, Campochiaro PA, Conway BP (1990) Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci 31:14–28PubMed

Wiedemann P (1992) Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 36:373–384PubMedCrossRef

Kon CH, Asaria RH, Occleston NL, Khaw PT, Aylward GW (2000) Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol 84:506–511PubMedPubMedCentralCrossRef

Nagasaki H, Shinagawa K, Mochizuki M (1998) Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 17:77–98PubMedCrossRef

Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW (2001) Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial. Ophthalmology 108:1179–1183PubMedCrossRef

10.

Wiedemann P, Hilgers RD, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126:550–559PubMedCrossRef

11.

Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037–1053PubMedCrossRef

12.

Hanash SM (2000) Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 21:1202–1209PubMedCrossRef

13.

Matsumoto H, Komori N (2000) Ocular proteomics: cataloging photoreceptor proteins by two-dimensional gel electrophoresis and mass spectrometry. Methods Enzymol 316:492–511PubMedCrossRef

14.

Roepstorff P (1997) Mass spectrometry in protein studies from genome to function. Curr Opin Biotechnol 8:6–13PubMedCrossRef

15.

Yates JR 3rd (1998) Database searching using mass spectrometry data. Electrophoresis 19:893–900PubMedCrossRef

16.

Kristensen DB, Imamura K, Miyamoto Y, Yoshizato K (2000) Mass spectrometric approaches for the characterization of proteins on a hybrid quadrupole time-of-flight (Q-TOF) mass spectrometer. Electrophoresis 21:430–439PubMedCrossRef

17.

Kuo HK, Wu PC, Yang PM, Chen YH, Wu YC, Hu DN (2007) Effects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathy. J Ocul Pharmacol Ther 23:14–20PubMedCrossRef

18.

Lee JJ, Park JK, Kim YT, Kwon BM, Kang SG, Yoo YD, Yu YS, Chung H (2002) Effect of 2′-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model. Invest Ophthalmol Vis Sci 43:3117–3124PubMed

19.

Mandelcorn MS, Machemer R, Fineberg E, Hersch SB (1975) Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants. Am J Ophthalmol 80:227–237PubMedCrossRef

20.

Fastenberg DM, Diddie KR, Dorey K, Ryan SJ (1982) The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am J Ophthalmol 93:565–572PubMedCrossRef

21.

Yamane K, Minamoto A, Yamashita H, Takamura H, Miyamoto-Myoken Y, Yoshizato K, Nabetani T, Tsugita A, Mishima HK (2003) Proteome analysis of human vitreous proteins. Mol Cell Proteomics 2:1177–1187PubMedCrossRef

22.

Yu J, Liu F, Cui SJ, Liu Y, Song ZY, Cao H, Chen FE, Wang WJ, Sun T, Wang F (2008) Vitreous proteomic analysis of proliferative vitreoretinopathy. Proteomics 8:3667–3678PubMedCrossRef

23.

Ando N, Sen HA, Berkowitz BA, Wilson CA, de Juan E Jr (1994) Localization and quantitation of blood–retinal barrier breakdown in experimental proliferative vitreoretinopathy. Arch Ophthalmol 112:117–122PubMedCrossRef

24.

Little BC, Ambrose VM (1991) Blood–aqueous barrier breakdown associated with rhegmatogenous retinal detachment. Eye (Lond) 5(Pt 1):56–62CrossRef

25.

Kon CH, Occleston NL, Aylward GW, Khaw PT (1999) Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 40:705–712PubMed

26.

Pastor JC, de la Rua ER, Martin F (2002) Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 21:127–144PubMedCrossRef

27.

Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, Jia Y, Mikolajczyk M, Boretti FS, Schoedon G, Alayash AI, Schaer DJ (2009) Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113:2578–2586PubMedCrossRef

28.

de Kleijn DP, Smeets MB, Kemmeren PP, Lim SK, Van Middelaar BJ, Velema E, Schoneveld A, Pasterkamp G, Borst C (2002) Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring. FASEB J 16:1123–1125PubMed

29.

Padma T, Murty JS, Satapathy M (1980) Haptoglobin pattern in retinal detachments. Indian J Med Res 71:914–917PubMed

30.

Chignell AH, Carruthers M, Rahi AH (1971) Clinical, biochemical, and immunoelectrophoretic study of subretinal fluid. Br J Ophthalmol 55:525–532PubMedPubMedCentralCrossRef

31.

Getz RK, Kennedy BG, Mangini NJ (1999) Transthyretin localization in cultured and native human retinal pigment epithelium. Exp Eye Res 68:629–636PubMedCrossRef

32.

Pfeffer BA, Becerra SP, Borst DE, Wong P (2004) Expression of transthyretin and retinol binding protein mRNAs and secretion of transthyretin by cultured monkey retinal pigment epithelium. Mol Vis 10:23–30PubMed

33.

Delcourt C, Dupuy AM, Carriere I, Lacroux A, Cristol JP (2005) Albumin and transthyretin as risk factors for cataract: the POLA study. Arch Ophthalmol 123:225–232PubMedCrossRef

34.

Duan X, Lu Q, Xue P, Zhang H, Dong Z, Yang F, Wang N (2008) Proteomic analysis of aqueous humor from patients with myopia. Mol Vis 14:370–377PubMedPubMedCentral

35.

Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14:835–846PubMed

36.

Sandgren O (1995) Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 40:173–196PubMedCrossRef

37.

Van Aken E, De Letter EA, Veckeneer M, Derycke L, van Enschot T, Geers I, Delanghe S, Delanghe JR (2009) Transthyretin levels in the vitreous correlate with change in visual acuity after vitrectomy. Br J Ophthalmol 93:1539–1545PubMedCrossRef

38.

Baudouin C, Hofman P, Brignole F, Bayle J, Loubiere R, Gastaud P (1991) Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy. Ophthalmologica 203:38–46PubMedCrossRef

39.

Charteris DG, Hiscott P, Grierson I, Lightman SL (1992) Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology 99:1364–1367PubMedCrossRef

40.

Elner SG, Elner VM, Pavilack MA, Todd RF 3rd, Mayo-Bond L, Franklin WA, Strieter RM, Kunkel SL, Huber AR (1992) Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest 66:200–211PubMed

41.

Baudouin C, Fredj-Reygrobellet D, Gordon WC, Baudouin F, Peyman G, Lapalus P, Gastaud P, Bazan NG (1990) Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy. Am J Ophthalmol 110:593–598PubMedCrossRef

42.

Clausen R, Weller M, Wiedemann P, Heimann K, Hilgers RD, Zilles K (1991) An immunochemical quantitative analysis of the protein pattern in physiologic and pathologic vitreous. Graefes Arch Clin Exp Ophthalmol 229:186–190PubMedCrossRef

43.

Weller M, Clausen R, Bresgen M, Heimann K, Wiedemann P (1990) Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders. Int Ophthalmol 14:277–283PubMedCrossRef

44.

Urade Y, Eguchi N (2002) Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 68–69:375–382PubMedCrossRef

45.

Urade Y, Hayaishi O (2000) Prostaglandin D synthase: structure and function. Vitam Horm 58:89–120PubMedCrossRef

46.

Beuckmann CT, Gordon WC, Kanaoka Y, Eguchi N, Marcheselli VL, Gerashchenko DY, Urade Y, Hayaishi O, Bazan NG (1996) Lipocalin-type prostaglandin D synthase (beta-trace) is located in pigment epithelial cells of rat retina and accumulates within interphotoreceptor matrix. J Neurosci 16:6119–6124PubMed

47.

Goh Y, Urade Y, Fujimoto N, Hayaishi O (1987) Content and formation of prostaglandins and distribution of prostaglandin-related enzyme activities in the rat ocular system. Biochim Biophys Acta 921:302–311PubMedCrossRef

48.

Logdberg L, Wester L (2000) Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta 1482:284–297PubMedCrossRef

49.

Taniguchi H, Mohri I, Okabe-Arahori H, Aritake K, Wada K, Kanekiyo T, Narumiya S, Nakayama M, Ozono K, Urade Y, Taniike M (2007) Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. J Neurosci 27:4303–4312PubMedCrossRef

50.

Taniguchi H, Mohri I, Okabe-Arahori H, Kanekiyo T, Kagitani-Shimono K, Wada K, Urade Y, Nakayama M, Ozono K, Taniike M (2007) Early induction of neuronal lipocalin-type prostaglandin D synthase after hypoxic–ischemic injury in developing brains. Neurosci Lett 420:39–44PubMedCrossRef

51.

Govoni S, Masoero E, Favalli L, Rozza A, Scelsi R, Viappiani S, Buccellati C, Sala A, Folco G (2001) The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci Lett 303:91–94PubMedCrossRef

52.

Kagitani-Shimono K, Mohri I, Oda H, Ozono K, Suzuki K, Urade Y, Taniike M (2006) Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol Appl Neurobiol 32:64–73PubMedCrossRef

53.

Taniike M, Mohri I, Eguchi N, Beuckmann CT, Suzuki K, Urade Y (2002) Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J Neurosci 22:4885–4896PubMed

54.

Gerashchenko DY, Beuckmann CT, Marcheselli VL, Gordon WC, Kanaoka Y, Eguchi N, Urade Y, Hayaishi O, Bazan NG (1998) Localization of lipocalin-type prostaglandin D synthase (beta-trace) in iris, ciliary body, and eye fluids. Invest Ophthalmol Vis Sci 39:198–203PubMed

55.

Giacomelli S, Leone MG, Grima J, Silvestrini B, Cheng CY (1996) Astrocytes synthesize and secrete prostaglandin D synthetase in vitro. Biochim Biophys Acta 1310:269–276PubMedCrossRef

56.

Jaggi GP, Flammer J, Huber AR, Killer HE (2008) Lipocalin-like prostaglandin D synthase in subretinal fluid of detached retinas in humans. Retina 28:858–863PubMedCrossRef

57.

Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H (2008) Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest 118:3367–3377PubMedPubMedCentralCrossRef

58.

Ganss B, Jheon A (2004) Zinc finger transcription factors in skeletal development. Crit Rev Oral Biol Med 15:282–297PubMedCrossRef

59.

Tupler R, Perini G, Green MR (2001) Expressing the human genome. Nature 409:832–833PubMedCrossRef

60.

McConnell BB, Ghaleb AM, Nandan MO, Yang VW (2007) The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29:549–557PubMedPubMedCentralCrossRef

61.

Peng H, Du ZW, Zhang JW (2006) Identification and characterization of a novel zinc finger protein (HZF1) gene and its function in erythroid and megakaryocytic differentiation of K562 cells. Leukemia 20:1109–1116PubMedCrossRef

62.

Takahashi Y, Fujioka Y, Takahashi T, Domoto K, Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M (2005) Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells. Life Sci 77:670–682PubMedCrossRef

63.

Li H, Wang H, Wang F, Gu Q, Xu X (2011) Snail involves in the transforming growth factor beta1-mediated epithelial–mesenchymal transition of retinal pigment epithelial cells. PLoS One 6:e23322PubMedPubMedCentralCrossRef

64.

Watabe Y, Baba Y, Nakauchi H, Mizota A, Watanabe S (2011) The role of Zic family zinc finger transcription factors in the proliferation and differentiation of retinal progenitor cells. Biochem Biophys Res Commun 415:42–47PubMedCrossRef

Titel: The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy
verfasst von: Hsi-Kung Kuo
Yi-Hao Chen
Faye Huang
Yi-Chan Wu
Jentaie Shiea
Pei-Chang Wu
Publikationsdatum: 01.02.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2016
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-015-3022-2

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2016

Influence of optic disc leakage on objective optic nerve head assessment in patients with uveitis

25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears

Marked dissociation of photopic and mesopic contrast sensitivity even in normal observers

A modified scleral dissection technique with suprachoroidal drainage for canaloplasty

ABCA1 rs1883025 polymorphism and risk of age-related macular degeneration

Steady-state multifocal visual evoked potential (ssmfVEP) using dartboard stimulation as a possible tool for objective visual field assessment

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde